期刊文献+

脂肪源性γ-氨基丁酸能神经元移植治疗帕金森病大鼠的疗效观察 被引量:2

Effect of adipose-derived GABAergic neuron transplantation in treatment of Parkinson's disease in rats
原文传递
导出
摘要 目的研究脂肪来源的间充质干细胞诱导为γ-氨基丁酸(GABA)能神经元的方法,探讨GABA能神经元移植治疗帕金森病模型大鼠的疗效。方法取大鼠脂肪组织,利用本单位自行配制的神经干细胞培养基诱导分化为神经干细胞,利用GABA能神经元定向诱导培养基对神经干细胞进行二次定向诱导.并对其进行特异性鉴定。将诱导成功的神经干细胞、GABA能神经元分别移植入帕金森病大鼠模型的丘脑底核,在移植后2周、4周、8周观察大鼠行为学变化情况。结果体外扩增的脂肪间充质干细胞经过神经干细胞培养基培养后,细胞定向诱导并表达巢蛋白、神经元烯醇化酶fNSE)等神经干细胞标志。经GABA能神经元定向分化培养基二次诱导后,免疫荧光鉴定细胞GAD65阳性。立体定向移植细胞4周后,神经干细胞组与GABA能神经元组的大鼠行为学均得到改善,且GABA能神经元组的疗效更加显著。结论脂肪来源的间充质干细胞可诱导分化为GABA能神经元,将其移植人大鼠的丘脑底核可以明显改善帕金森病大鼠的运动功能。 Objective To investigate the method for inducing GABAergic neurons from adipose-derived mesenchymal stern cells (ADSCs) and observe the effect of transplantation of these neurons in the treatment of parkinsonian rats. Methods ADSCs isolated from rat inguinal fat pads were digested with collagenase, cultured and passaged in vitro, from which neural stem cells were induced using the neural stem cell culture medium prepared by our institute and identified for the stem cell markers. The neural stem cells obtained were further induced using the GABAergic neuron culture medium. After identification for the marker GAD65, the GABAergic neurons or the neural stem cells were stereotaxically transplanted into the subthalamic nucleus of the Parkinsonian rats, and the behavioral changes of the rats were observed at 2, 4 and 8 weeks after the cell transplantation. Results The neural stem cells differentiated from the ADSCs expressed the stem cell markers including nestin and neuron-specific enolase. After the second induction, the cells were positive for GAD65 as identified by immunofluorescence staining. Four weeks after transplantation of the neural stem cells and GABAergic neurons into the subthalamic nucleus, the parkinsonian rats exhibited significantly improved rotational behavior induced by apomorphine, and the improvement was especially obvious in rats with GABAergic cell transplantation. Conclusion GABAergic neurons can be induced from the rat ADSCs and transplantation of these neurons into the subthalamic nucleus can produce obvious behavioral improvement in rat models of Parkinson disease.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第2期129-132,共4页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30772232)
关键词 帕金森病 神经干细胞 Γ-氨基丁酸能神经元 Parkinsonian rats Neural stem cells Gamma aminobutyric acid neurons
  • 相关文献

参考文献8

  • 1Huse DM, Schulman K, Orsini L, et al. Burden of illness in Parkinson's disease [J]. Mov Disord, 2005, 20(11): 1449-1454.
  • 2Liu WG, Lu GQ, Li B, et al. Dopaminergic neuroprotection by neurturin-expressing c 17.2 neural stem cells in a rat model of Parkinson's disease[J]. Parkinsonism Relat Disord, 2007, 13(2): 77-88.
  • 3刘卫平,潘灏,章翔,姬西团,王彦刚,王西玲,梁景文.神经干细胞原代培养及GABA能神经元的诱导分化[J].中华神经外科疾病研究杂志,2005,4(1):44-47. 被引量:14
  • 4Paxinos G, Watosn C. The rat brain in Stereo taxic Coordinates[M]. New York: Academic Press, 1986: 128-140.
  • 5Tan LC, Venketasubramanian N, Jamora RD, et al. Incidence of Parkinson ' s disease in Singapore [J]. Parkinsonism Relat Disord, 2007, 13(1): 40-43.
  • 6During MJ, Kaplitt MG, Stem MB, et al. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation[J]. Hum Gene Ther, 2001, 12(12): 1589-1591.
  • 7Vale S. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?[J]. Exp Biol Med, 2008, 233(8): 941-951.
  • 8陈锦华,杨辉,尹昌林,张治元,刘仕勇,何家全,高方友.BMP2在SVZa神经干细胞向GABA能神经元分化中的调控作用[J].第三军医大学学报,2007,29(8):699-701. 被引量:7

二级参考文献20

  • 1Yamamoto N,Yamamoto S,Inagaki F,et al.Role of Deltex-1 as a transcriptional regulator downsteam the Notch receptor [J].J Biol Chem,2001,276(48):45031-45040.
  • 2Mizuguchi R,Sugimori M,Takebayashi H,et al.Combinatorial roles of olig 2 and neurogenin 2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons [J].Neuron,2001,31(5):757-771.
  • 3Sestan N,Artavanis-Tsakonas S,Rakic P.Contact-dependent inhibition of cortical neurite growth mediated by notch signaling [J].Science,1999,286(5440):741-746.
  • 4Kageyama R,Nakanishi S.Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system [J].Curr Opin Genet Dev,1997,7(5):659-665.
  • 5Vetter M.A turn of the he lix:preventing the glial fate [J].Neuron,2001,29(3):559-562.
  • 6Nieto M,Schuurmans C,Britz O,et al.Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors [J].Neuron,2001,29(2):401-413.
  • 7Lee SK,Pfaff SL.Transcriptional networks regulating neuronal identity in the developing spinal cord [J].Nat Neurosci,2001,Suppl:1183-1191.
  • 8Cai L,Morrow EM,Cepko CL.Misexpression of basic helix-loop-helix genes in the murine cerebral cortex affects cell fate choices and neuronal survival [J].Development,2000,127(14):3021-3030.
  • 9Bae S,Bessho Y,Hojo M,et al.The bHLH gene Hes6,an inhibitor of Hes1,promotes neuronal differentiation [J].Development,2000,127(13):2933-2943.
  • 10Ishibashi M,Moriyoshi K,Sasai Y,et al.Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system [J].EMBO J,1994,13(8):1799-1805.

共引文献19

同被引文献21

  • 1刘卫平,潘灏,章翔,姬西团,王彦刚,王西玲,梁景文.神经干细胞原代培养及GABA能神经元的诱导分化[J].中华神经外科疾病研究杂志,2005,4(1):44-47. 被引量:14
  • 2Fu YS Cheng YC Lin MY Cheng H Chu PM Chou SC Shih YH Ko MH Sung MS.Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism[J].中国生物学文摘,2006,20(10):22-23. 被引量:140
  • 3Driver J A, Logroscino G, Gaziano J M, et al. Incidence and remaining lifetime risk of Parkinson disease in advanced age[J]. Neurology, 2009, 72(5) :432-438.
  • 4Kuzuhara S. Treatment of Parkinson's disease at present and in the future [J ]. Rinsho Shinkeigaku, 2008,48 (11 ) :835-843.
  • 5Vails-Sole J, Compta Y, Costa J, et al. Human central nervous system circuits examined through the electrodes implanted for deep brain stimulation [J]. Clin Neurophysiol, 2008,119(6) : 1219-1231.
  • 6Lelan F, Damier P. Grafted dopaminergic neurons are targeted by the disease process in Parkinson's disease [ J ]. Med Sci (Paris), 2009,25 (1): 15-16.
  • 7Mochizuki H, Yasuda T, Mouradian M M. Advances in gene therapy for movement disorders [J]. Neurotherapeutics, 2008,5(2):260-269.
  • 8Luo J, Kaplitt M G, Fitzsimons H L, et al. Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model [J]. Science, 2002,298(5592): 425-429.
  • 9Kim J, Yoon Y S, Lee H, et al. AAV-GAD gene for rat models of neuropathic pain and Parkinson's disease[J]. Acta Neurochir Suppl, 2008,101 (1):99-105.
  • 10Kaplitt M G, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease : an open label, phase I trial [ J ]. Lancet, 2007,369 (9579) : 2097-2105.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部